HIV vaccine trial in Africa halted after disappointing initial results

July 24, 2024 Health Trends, Health Trends - USA

Dar es Salaam. A large-scale HIV vaccine trial conducted across Eastern and Southern Africa from 2020 to 2024 has concluded without success.

The PrEPVacc trial, which included sites in Tanzania, Uganda and South Africa, failed to demonstrate that either of the two experimental vaccine…

Source link

A note to our visitors

This website has updated its privacy policy in compliance with changes to European Union data protection law, for all members globally. We’ve also updated our Privacy Policy to give you more information about your rights and responsibilities with respect to your privacy and personal information. Please read this to review the updates about which cookies we use and what information we collect on our site. By continuing to use this site, you are agreeing to our updated privacy policy.

HIV vaccine trial in Africa halted after disappointing initial results

Recent Posts

Recent Comments